Your browser doesn't support javascript.
loading
Real-world study of efficacy, risk management and reasons for discontinuation of natalizumab for treatment of multiple sclerosis in Russia.
Evdoshenko, Evgeniy; Stepanova, Alexandra; Shumilina, Maria; Davydovskaya, Maria; Khachanova, Natalia; Neofidov, Nikolay; Kalinin, Ivan; Popova, Ekaterina; Dubchenko, Ekaterina; Pozhidaeva, Natalia; Volkov, Andrey; Sivertseva, Stella; Prilenskaya, Anna; Malkova, Nadezhda; Korobko, Denis; Vergunova, Ilona; Shchur, Sergey; Makshakov, Gleb.
Afiliação
  • Evdoshenko E; SPb Center of Multiple Sclerosis and AID (SBIH City Clinical Hospital #31), St. Petersburg, Russia.
  • Stepanova A; SPb Center of Multiple Sclerosis and AID (SBIH City Clinical Hospital #31), St. Petersburg, Russia.
  • Shumilina M; SPb Center of Multiple Sclerosis and AID (SBIH City Clinical Hospital #31), St. Petersburg, Russia.
  • Davydovskaya M; State Budgetary Institution of Moscow City "Clinical Trials and Healthcare Technology Assessment Scientific-Research Centre of Moscow Department of Healthcare", Moscow, Russian Federation.
  • Khachanova N; Pirogov Russian National Research Medical University, Moscow, Russia.
  • Neofidov N; Pirogov Russian National Research Medical University, Moscow, Russia.
  • Kalinin I; SPb Center of Multiple Sclerosis and AID (SBIH City Clinical Hospital #31), St. Petersburg, Russia.
  • Popova E; SPb Center of Multiple Sclerosis and AID (SBIH City Clinical Hospital #31), St. Petersburg, Russia.
  • Dubchenko E; City Clinical Hospital # 24, Moscow, Russia.
  • Pozhidaeva N; City Clinical Hospital # 81, Moscow, Russia.
  • Volkov A; City Clinical Hospital # 81, Moscow, Russia.
  • Sivertseva S; City Clinical Hospital # 71, Moscow, Russia.
  • Prilenskaya A; "Medical Sanitary Unit «Neftyanik¼, Tyumen Multiple Sclerosis Center, Tyumen, Russia.
  • Malkova N; "Medical Sanitary Unit «Neftyanik¼, Tyumen Multiple Sclerosis Center, Tyumen, Russia.
  • Korobko D; State Novosibirsk Regional Clinical Hospital, Center of MS and other AID of Nervous System, Novosibirsk, Russia.
  • Vergunova I; State Novosibirsk Medical University, Novosibirsk, Russia.
  • Shchur S; State Novosibirsk Regional Clinical Hospital, Center of MS and other AID of Nervous System, Novosibirsk, Russia.
  • Makshakov G; State Novosibirsk Regional Clinical Hospital, Center of MS and other AID of Nervous System, Novosibirsk, Russia.
PLoS One ; 14(5): e0217303, 2019.
Article em En | MEDLINE | ID: mdl-31136608
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esclerose Múltipla Recidivante-Remitente / Natalizumab / Fatores Imunológicos Tipo de estudo: Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male País como assunto: Asia / Europa Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esclerose Múltipla Recidivante-Remitente / Natalizumab / Fatores Imunológicos Tipo de estudo: Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male País como assunto: Asia / Europa Idioma: En Ano de publicação: 2019 Tipo de documento: Article